La Jolla Pharmaceutical Overview

La Jolla Pharmaceutical Operating Income

Operating Income for LJPC.

Quarterly Operating Income

$4.85M

↑ 27.79% YoY

As of Jun 30, 2022

Annual Operating Income (TTM)

$13.99M

↑ 67.21% YoY

Trailing 12 months ending Jun 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin